Glacier Peak Capital’s Allergan plc AGN Stock Holding History

Glacier Peak Capital’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-14,600	Closed	-$2.14M	–	93
2019 Q1	$2.14M	Buy	+14,600	New	+$2.12M	1.95%	15

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Glacier Peak Capital's AGN Position: Q2 2019 in Review

Glacier Peak Capital sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 14,600 shares — an estimated $2.14M sold.

Glacier Peak Capital first reported a position in AGN in Q1 2019 and held it in 1 quarter. The position peaked at $2.14M in Q1 2019. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

Glacier Peak Capital reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
Glacier Peak Capital sold 14,600 Allergan plc shares in Q2 2019, an estimated $2.14M.
Glacier Peak Capital first reported a position in Allergan plc in Q1 2019 and held it in 1 quarter.
Glacier Peak Capital's Allergan plc position peaked at $2.14M in Q1 2019.
971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Glacier Peak Capital's 13F filing for Q2 2019, filed 12 Aug 2019.